Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 10 of 10 entries
View as:

VIBRANT Study of Vurolenatide in Adult Patients With Short Bowel Syndrome.

Phase: N/A Priority: Normal
NCT ID: NCT04988997 Org: User:
Start: 06/14/21 End: 08/24/22 Due: 08/24/23

Safety and Tolerability Study of Larazotide Acetate in Celiac Disease Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00362856 Org: User:
Start: 09/13/06 End: 03/06/07 Due: 03/06/08

Study of the Efficacy of Larazotide Acetate to Treat Celiac Disease

Phase: N/A Priority: Normal
NCT ID: NCT00889473 Org: User:
Start: 04/30/09 End: 04/30/10 Due: 04/30/11

Safety Study of Larazotide Acetate to Treat Celiac Disease.

Phase: N/A Priority: Normal
NCT ID: NCT00386165 Org: User:
Start: 11/29/05 End: 01/26/06 Due: 01/26/07

Safety of Larazotide Acetate in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00386490 Org: User:
Start: 01/10/06 End: 02/27/06 Due: 02/27/07

Randomized, Double-Blind, Placebo-Controlled Study of Larazotide Acetate in Subjects With Active Celiac Disease

Phase: N/A Priority: Normal
NCT ID: NCT00620451 Org: User:
Start: 02/29/08 End: 12/31/09 Due: 12/31/10

Proof of Concept Study in Patients With Short Bowel Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT04379856 Org: User:
Start: 06/23/20 End: 12/31/20 Due: 12/31/21

Study to Assess the Efficacy of Larazotide Acetate for the Treatment of Celiac Disease

Phase: N/A Priority: Normal
NCT ID: NCT00492960 Org: User:
Start: 08/31/07 End: 03/31/09 Due: 03/31/10

Study to Evaluate the Efficacy and Safety of Larazotide Acetate for the Relief of CeD Symptoms

Phase: N/A Priority: Normal
NCT ID: NCT03569007 Org: User:
Start: 05/29/19 End: 07/21/22 Due: 07/21/23

A Double-blind Placebo-controlled Study to Evaluate Larazotide Acetate for the Treatment of Celiac Disease

Phase: N/A Priority: Normal
NCT ID: NCT01396213 Org: User:
Start: 11/07/11 End: 08/20/13 Due: 08/20/14